Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Holding the Right CARDs with Tecan Cavro® Components

Published: Tuesday, June 11, 2013
Last Updated: Tuesday, June 11, 2013
Bookmark and Share
Rheonix provides complete automation of sample processing and analysis using CARD® technology.

Rheonix Inc has integrated Tecan’s Cavro® Air Displacement Pipettor (ADP) into its EncompassMDx™ molecular platform, providing complete automation of sample processing and analysis using Rheonix CARD® technology.

The CARD system allows complete automation of nucleic acid testing of various biological sample types, including FFPE (formalin fixed paraffin embedded) samples, using a single disposable device.

Each CARD contains all the pumps, valves, microchannels, reservoirs and reaction chambers required to perform a wide range of assays, using patented technology to control fluid flow.

Dr Richard Montagna, Senior Vice President for Corporate Business Development and Scientific Affairs at Rheonix, explained why Rheonix chose Tecan: “Rather than develop our own pipetting system for reagent addition, our engineers looked at third-party devices from several OEM manufacturers to perform this essential task. We chose the Cavro ADP for its combination of accuracy, robustness and competitive pricing, and we are not aware of any other pipetting system that has the same breadth of capabilities. It can handle a wide range of materials and volumes, and we were confident that this flexibility, combined with the use of Tecan’s high quality disposable tips, would allow constant and reliable walkaway operation of the EncompassMDx workstation.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Boston Plays Host to the Fifth Tecan Symposium
This year’s symposium explored the topic of ‘Mass spectrometry - the expanding role in life sciences and diagnostics.’
Wednesday, December 12, 2012
Tecan and Attana Extend Distribution Agreement
Tecan to distribute Attana's label-free biosensor instruments and QCM assay technology in Europe.
Friday, October 14, 2011
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos